Descripción del proyecto
Prepararse para satisfacer las necesidades urgentes de la siguiente pandemia
La pandemia de COVID-19 ha puesto de manifiesto la falta de respuesta a la gran demanda de productos y servicios médicos. Esto ha hecho necesario un nuevo método para satisfacer los picos de demanda durante las crisis sanitarias. En el proyecto RESERVIST, financiado con fondos europeos, se abordará este problema mediante la creación de una red básica de centros de fabricación y distribución para satisfacer las necesidades urgentes de suministro en cuarenta y ocho horas. Esto se logrará conectando a las empresas necesarias, optimizando la producción y la distribución y colaborando con la comunidad mundial de fabricantes para satisfacer el aumento de la demanda. El objetivo es aprovechar las últimas innovaciones, aumentar la flexibilidad de la producción y garantizar la entrega puntual de suministros y servicios para la próxima crisis sanitaria.
Objetivo
RESERVIST aims to establish ‘reservist cells’ that in times of crises can be activated within 48hrs to switch to manufacturing medical products and services that are spiking in demand. Such a ‘reservist cell’ will consist of (i) a backbone network of core companies for manufacturing and testing; (ii) an extended network for further capacities (eg local provision, packaging, distribution, customization,…); (iii) a digital coordination platform and (iv) a pool of experts from the companies of the network. These cells will become operational in case of an emergency/pandemic but to make economic sense, the same approach of rapid flexibility and adaptability will be used to deal with surging demand in ‘normal circumstances’.
To realise this concept, we will first work on three levels individually: network level, connected manufacturing/digital manufacturing level and technical level, the latter referring to tweaking manufacturing lines, developing required materials and establishing links with testing/certification. Next, we will demonstrate the repurposing of 5 existing manufacturing lines within 48hrs towards manufacturing of ‘textile PPE’ (surgical and respiratory face masks, medical aprons) and ‘respiratory ventilators’ (invasive and non invasive) that comply with necessary testing and certification and proceed with the embedment of the reservist cells at the partners in the network. We will develop blueprints for further take-up and replication of the concept to other sectors. Within the project we will develop two replication demos: ‘disinfection equipment’ and ‘emergency medical equipement’. To support the Cells we will tap into the worldwide maker community and into relevant OITBs and networks.
The consortium is strongly industry-driven, including 4 LE and 7 SMEs coming from 7 EU countries. To maximise impact, we will extend our partner network and our Impact Support Group (18 Support Letters provided at proposal stage).
Ámbito científico
- medical and health scienceshealth scienceshealth care serviceseHealth
- medical and health sciencesclinical medicineemergency medicine
- medical and health scienceshealth sciencespublic healthepidemiologypandemics
- engineering and technologymaterials engineeringtextiles
- engineering and technologyelectrical engineering, electronic engineering, information engineeringinformation engineeringtelecommunicationstelecommunications networksdata networks
Palabras clave
Programa(s)
Tema(s)
Convocatoria de propuestas
H2020-SC1-PHE-CORONAVIRUS-2020-2
Consulte otros proyectos de esta convocatoriaConvocatoria de subcontratación
H2020-SC1-PHE-CORONAVIRUS-2020-2-NMBP
Régimen de financiación
IA - Innovation actionCoordinador
1070 BRUXELLES
Bélgica
Organización definida por ella misma como pequeña y mediana empresa (pyme) en el momento de la firma del acuerdo de subvención.